GNR 003

Drug Profile

GNR 003

Alternative Names: GNR-003; Human blood coagulation factor IX; Innonafactor

Latest Information Update: 03 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator International Biotech Center Generium
  • Developer International Biotechnology Center Generium
  • Class Antihaemorrhagics; Blood coagulation factors
  • Mechanism of Action Blood coagulation factor replacements; Factor IX stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Haemophilia B

Most Recent Events

  • 27 Oct 2015 Registered for Haemophilia B in Russia (IV) before October 2015
  • 26 Oct 2015 Preregistration for Haemophilia B in Russia (IV) before October 2015
  • 25 Oct 2015 Phase-I clinical trials in Haemophilia B in Russia (IV) before October 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top